LUMO Archived Articles
Lumos Pharma (LUMO): Navigating the Rare Disease Landscape with Promising Oral Therapeutics
Published on November 17, 2024
Lumos Pharma Reports Promising Second Quarter 2024 Results and Provides Update on Planned Phase 3 Trial for LUM-201
Published on September 24, 2024